We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $42.5B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+0.3%
1 Year Est. Return
+18.19%
3 Year Est. Return
+63.85%
5 Year Est. Return
+89.78%
10 Year Est. Return
+309.54%
AUM
$41.1B
AUM Growth
+$1.81B
Cap. Flow
+$2.06B
Cap. Flow %
5%
Top 10 Hldgs %
42.56%
Holding
315
New
30
Increased
123
Reduced
65
Closed
3

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$267M
2
DE icon
Deere & Co
DE
+$139M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$117M
4
JPM icon
JPMorgan Chase
JPM
+$114M
5
CVX icon
Chevron
CVX
+$88.5M

Top Sells

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$90M
2
CMCSA icon
Comcast
CMCSA
+$36M
3
UNP icon
Union Pacific
UNP
+$19.2M
4
HES
Hess
HES
+$19.2M
5
KMPR icon
Kemper
KMPR
+$17.6M

Sector Composition

Rank Sector Weight
1 Technology 30.18%
2 Financials 18.99%
3 Healthcare 11.19%
4 Consumer Staples 11.19%
5 Energy 8.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DLR icon
101
Digital Realty Trust
DLR
$66.5B
$11.1M 0.03%
62,447
INTC icon
102
Intel
INTC
$513B
$9.87M 0.02%
492,461
-21,340
-4% -$481K
PLD icon
103
Prologis
PLD
$129B
$9.3M 0.02%
87,946
+1,047
+1% +$120K
CPRT icon
104
Copart
CPRT
$28.7B
$9.1M 0.02%
+158,575
New +$9.03M
OKE icon
105
Oneok
OKE
$59.7B
$9.05M 0.02%
90,108
-750
-0.8% -$76.7K
AMGN icon
106
Amgen
AMGN
$203B
$8.55M 0.02%
32,817
+8,215
+33% +$2.44M
LMT icon
107
Lockheed Martin
LMT
$123B
$8.09M 0.02%
16,642
+515
+3% +$281K
SBUX icon
108
Starbucks
SBUX
$110B
$7.76M 0.02%
85,065
-184
-0.2% -$17.8K
ROK icon
109
Rockwell Automation
ROK
$46.3B
$7.68M 0.02%
26,868
BSM icon
110
Black Stone Minerals
BSM
$3.23B
$7.16M 0.02%
490,740
PFE icon
111
Pfizer
PFE
$157B
$7.14M 0.02%
269,075
-8,576
-3% -$233K
AMT icon
112
American Tower
AMT
$82.8B
$6.77M 0.02%
36,901
+5,090
+16% +$1.05M
OVV icon
113
Ovintiv
OVV
$18.5B
$6.72M 0.02%
165,824
K
114
DELISTED
Kellanova
K
$6.29M 0.02%
77,630
-2,662
-3% -$215K
SCI icon
115
Service Corp International
SCI
$11.1B
$5.93M 0.01%
74,325
AON icon
116
Aon
AON
$64.6B
$5.91M 0.01%
+16,442
New +$6.05M
BUD icon
117
AB InBev
BUD
$156B
$5.88M 0.01%
117,506
-32,074
-21% -$1.86M
DUK icon
118
Duke Energy
DUK
$91.8B
$5.77M 0.01%
53,546
+2,132
+4% +$242K
CARR icon
119
Carrier Global
CARR
$45.8B
$5.63M 0.01%
82,516
-201
-0.2% -$15.2K
HDB icon
120
HDFC Bank
HDB
$116B
$5.56M 0.01%
174,200
+7,110
+4% +$227K
HON icon
121
Honeywell
HON
$64.5B
$5.07M 0.01%
23,814
-259
-1% -$54K
QQQ icon
122
Invesco QQQ Trust
QQQ
$474B
$4.81M 0.01%
9,399
+4,415
+89% +$2.23M
ITW icon
123
Illinois Tool Works
ITW
$76.5B
$4.71M 0.01%
18,570
+62
+0.3% +$16.4K
EMR icon
124
Emerson Electric
EMR
$82B
$4.36M 0.01%
35,170
+7,320
+26% +$888K
CSX icon
125
CSX Corp
CSX
$90.1B
$4.32M 0.01%
133,884

Similar funds

Fayez Sarofim & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Fayez Sarofim & Co held 315 positions worth $41.1B, up 4.6% from $39.3B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Fayez Sarofim & Co deployed $2.06B of net new capital in Q4 2024, opening 30 new positions and adding to 123 existing holdings. Its largest new stake was Copart: 158,575 shares worth $9.1M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Novo Nordisk, an estimated $90M trimmed.

  • Fayez Sarofim & Co's largest Q4 2024 buy was Copart: 158,575 shares worth $9.1M.
  • Fayez Sarofim & Co added most to NVIDIA in Q4 2024, an estimated $267M increase.
  • Fayez Sarofim & Co's biggest Q4 2024 reduction was Novo Nordisk, cutting an estimated $90M.
  • Fayez Sarofim & Co fully exited Bruker in Q4 2024, selling an estimated $227K.
  • Fayez Sarofim & Co's ten largest holdings make up 43% of its $41.1B portfolio in Q4 2024.
  • Fayez Sarofim & Co opened 30 new positions and closed 3 in Q4 2024.
  • Fayez Sarofim & Co's portfolio value rose 4.6% quarter-over-quarter to $41.1B.

Based on Fayez Sarofim & Co's 13F filing for Q4 2024, filed 14 Feb 2025.